GPCM
Granite Point Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-110,000
| Closed | -$4.12M | – | 84 |
|
|
2016
Q4 | $4.12M | Buy |
+110,000
| New | +$4.12M | 3.28% | 6 |
|
|
2015
Q4 | – | Sell |
-3,708
| Closed | -$298K | – | 82 |
|
|
2015
Q3 | $298K | Sell |
3,708
-162
| -4% | -$13K | 0.2% | 69 |
|
|
2015
Q2 | $464K | Sell |
3,870
-1,130
| -23% | -$135K | 0.14% | 72 |
|
|
2015
Q1 | $522K | Hold |
5,000
| – | – | 0.19% | 72 |
|
|
2014
Q4 | $485K | Buy |
+5,000
| New | +$485K | 0.23% | 61 |
|